novel transcript, antisense to SOX6 (ENSG00000296405)

This entry refers to a non-coding RNA, characterized as an antisense transcript overlapping the SOX6 genomic locus (SOX6 is a well-characterized transcription factor important for development, neurogenesis, and cell lineage specification[1][3][5]). Widespread antisense transcription is known to influence sense transcript production and processing dynamics, particularly by altering chromatin states near gene promoters[2][4]. Specifically, elevated antisense transcription can decrease the production and processing rates of the corresponding sense transcript (here, SOX6), while increasing sense transcript stability, mediated in part through effects on histone acetylation and the action of chromatin modifiers such as Set3[2][4]. Despite these mechanistic insights, the antisense transcript "ENSG00000296405" itself is not a canonical therapeutic target, and its individual disease or drug relevance is currently unknown. Most research focuses on the consequences of antisense transcription for gene regulation, not on the antisense RNA as a distinct biological entity for therapeutic intervention[2][4]. This transcript is not a standard therapeutic target; SOX6 protein itself is more relevant for drug targeting and disease association[1][3][5]. This antisense transcript’s presence may only be relevant to basic research into gene expression regulation.

Other names

antisense to SOX6ENSG00000296405